Literature DB >> 17968465

Relaxation mechanisms of neferine on the rabbit corpus cavernosum tissue in vitro.

Jun Chen1, Jun Qi, Fang Chen, Ji-Hong Liu, Tao Wang, Jun Yang, Chun-Ping Yin.   

Abstract

AIM: To investigate the relaxation mechanisms of neferine (Nef) on the rabbit corpus cavernosum tissue in vitro.
METHODS: Strips of rabbit corpus cavernosum were mounted in organ chambers. The effects of Nef were examined on isolated muscle strips precontracted with phenylephrine (PE) alone, in the presence of N(W)-nitro-L-arginine (LNNA, a nitric oxide synthase inhibitor), 1-H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ, a guanylyl cyclase inhibitor), indomethacin (cyclooxygenase inhibitor), tetraethylammonium (Ca(2+)-activated K(+) channel blocker), 4-aminopiridine (4-AP, voltage dependent K(+) channel blocker) and glibenclamide (ATP sensitive K(+) channel blocker). The effects of Nef on KCl-induced contraction of isolated muscle strips were also investigated. The procedure of calcium absence-calcium addition was designed to observe the effect of Nef on two components of the contractile responses to PE based on the source of Ca(2+) (extracellular vs. intracellular).
RESULTS: Corpus cavernosum strips relaxed in response to Nef (10(-9)-10(-4) mol/L) in a concentration-dependent manner with an IC(50) of 4.60 X 10(-6) mol/L. However, they were not affected by LNNA, ODQ, indomethacin or K(+)-channel blockers. Nef (10(-6) mol/L, 10(-5) mol/L) concentration dependently reduced the maximal contraction response of isolated strips induced by KCl to 79.3%+/-5.5% and 61.5%+/-3.2%, respectively (P < 0.01). In the calcium absence-calcium addition procedure, Nef 10(-5) mol/L inhibited both intracellular calcium-dependent and extracellular calcium-dependent contraction induced by PE (2 X 10(-5) mol/L) (P < 0.05). The inhibition ratios were 26.2%+/-5.4% and 48.3%+/-7.6%, respectively.
CONCLUSION: The results of the present study suggest that Nef possesses a relaxant effect on rabbit corpus cavernosum tissues, which is attributable to the inhibition of extracellular Ca2+ influx and the inhibition of release of intracellular stored Ca(2+), but not mediated by the release of nitric oxide, prostaglandins or by the activation of potassium channels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968465     DOI: 10.1111/j.1745-7262.2007.00321.x

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  6 in total

1.  Neferine inhibits angiotensin II-stimulated proliferation in vascular smooth muscle cells through heme oxygenase-1.

Authors:  Xiao-chun Li; Guo-xin Tong; Yu Zhang; Shan-xin Liu; Qi-hui Jin; Huai-hong Chen; Peng Chen
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

2.  Neferine Protects Against Brain Damage in Permanent Cerebral Ischemic Rat Associated with Autophagy Suppression and AMPK/mTOR Regulation.

Authors:  Jirakhamon Sengking; Chio Oka; Piyawadee Wicha; Nuttapong Yawoot; Jiraporn Tocharus; Waraluck Chaichompoo; Apichart Suksamrarn; Chainarong Tocharus
Journal:  Mol Neurobiol       Date:  2021-09-08       Impact factor: 5.590

3.  Protective Effect of Neferine in Permanent Cerebral Ischemic Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms.

Authors:  Jirakhamon Sengking; Chio Oka; Nuttapong Yawoot; Jiraporn Tocharus; Waraluck Chaichompoo; Apichart Suksamrarn; Chainarong Tocharus
Journal:  Neurotox Res       Date:  2022-08-26       Impact factor: 3.978

Review 4.  Phytochemical Profile and Biological Activity of Nelumbo nucifera.

Authors:  Keshav Raj Paudel; Nisha Panth
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-30       Impact factor: 2.629

Review 5.  Traditional Chinese medical therapy for erectile dysfunction.

Authors:  Hao Li; Hongyang Jiang; Jihong Liu
Journal:  Transl Androl Urol       Date:  2017-04

6.  Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice.

Authors:  Xue Liu; Xiuhui Song; Jianjun Lu; Xueying Chen; Ershun Liang; Xiaoqiong Liu; Mingxiang Zhang; Yun Zhang; Zhanhui Du; Yuxia Zhao
Journal:  Oncotarget       Date:  2016-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.